Accelerating Medicines Partnership® (AMP®) Data Portals
Rapid data dissemination is integral to the success of the AMP program. Many AMP projects have made large amounts of data and analytical tools available for further research through public portals.
Accelerating Medicines Partnership® (AMP®) Data Portals
|
|
The AMP AD Knowledge Portal provides access to Alzheimer's disease data, analyses, and tools from AMP AD 1.0 and 2.0 |
|
|
The Agora platform provides information on the association of various genes with Alzheimer’s disease, as well as over 600 nascent drug targets for AD |
|
|
The AMP HF Knowledge Portal will provide access to existing and new data, analytical tools, and other resources for the study of heart failure with preserved ejection fraction (HFpEF) |
|
|
The AMP PD Knowledge Portal and Platform provides harmonized multi-omic data from thousands of PD study participants and healthy controls |
|
|
Genotype and Phenotype data from AMP RA/SLE are available through the National Library of Medicine’s database of Genotypes and Phenotypes (dbGaP), accession: phs001457. v1. p1. |
|
|
Additional AMP RA/SLE data is available through ImmPort, accession: SDY998, SDY999 |
|
|
The Type 2 Diabetes Knowledge Portal provides annotated and searchable genetic and genomic data from over 1.5 million individuals with type 2 diabetes |
ACCELERATING MEDICINES PARTNERSHIP and AMP are registered service marks of the U.S. Department of Health and Human Services.